Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705380 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
A Phase 2 study of Panic Disorder, sponsored by Boston University.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00705380: Completed Phase 2 study of Panic Disorder, sponsored by Boston University.
NCT00705380 is a Phase 2 study of Panic Disorder that has completed, run by Boston University. The registered enrollment target is 25 participants, below the 222-participant average among 25 other Panic Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705380, a Phase 2 study of Panic Disorder, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of cognitive behavioral therapy with a panic control treatment component in treating adolescents with panic disorder.
Conditions Studied
Interventions
- BEHAVIORAL Waitlist control
- BEHAVIORAL Cognitive behavioral therapy (CBT) with panic control treatment (PCT) for adolescents
Study Locations (1)
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 1998-07 |
| Est. Completion | 2004-10 |
| Phase | Phase 2 |
What the finished NCT00705380 record still lists
NCT00705380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 222-participant average among 25 other Panic Disorder trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Panic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Waitlist control is the first listed.
NCT00705380 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00705380 about?
NCT00705380 is a clinical study titled "Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder". This study will evaluate the effectiveness of cognitive behavioral therapy with a panic control treatment component in treating adolescents with panic disorder.
What is the current status of trial NCT00705380?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 1998-07. Estimated completion is 2004-10.
What conditions does trial NCT00705380 study?
This clinical trial studies the following conditions: Panic Disorder.
What interventions are being tested in trial NCT00705380?
The interventions under investigation include: Waitlist control (BEHAVIORAL), Cognitive behavioral therapy (CBT) with panic control treatment (PCT) for adolescents (BEHAVIORAL).
Who is sponsoring clinical trial NCT00705380?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00705380 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Panic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00705380's enrollment target sits among peer trials
25 24th of 25 higher than 1 of 25 other Panic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Panic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
COMPLETED · Phase 2
-
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression
COMPLETED · Phase 2
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia